Insulin-like growth factor binding protein-1 to screen for insulin resistance in children

Diabetes Technology and Therapeutics

Volumn 9, Issue 1, 2007, Pages 43-51

  Motaghedi, Roja ^a   Gujral, Sahil ^a   Sinha, Sunil ^b   Sison, Cristina ^c   Ten, Svetlana ^b   Maclaren, Noel K ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b North Shore Long Island Jewish Institute for Medical Research ^*  (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

^d BioSeek Endocrine Clinics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TOLBUTAMIDE;

ADOLESCENT; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; EARLY DIAGNOSIS; FEMALE; FREQUENTLY SAMPLED INTRAVENOUS GLUCOSE TOLERANCE TEST; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED STATES;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LIVER; MALE; MASS SCREENING; OVERWEIGHT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 33847203284     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.0056     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. http://www.cdc.gov/diabetes/pubs/factsheet.htm (accessed December 4, 2006).
2. Ogden CL, Flegal KM, Carol MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents 1999-2000. JAMA 2002;288:1728-1732.
3. Type 2 diabetes in children and adolescents. American Diabetes Association. Pediatrics 2000;105:671-680.
4. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH: Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-827.
5. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002;346:802-810.
6. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI: The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004;89:108-113.
7. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP: Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 2000;101:975-980.
8. McGill HC Jr, McMahan CA, Malcolm GT, Oalmann MC, Strong JP: Relation of glycohemolubin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 1995;15:431-140.
9. Gungor N, Thompson T, Sutton-Tyrrell K, Janosky J, Arslanian SA: Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care 2005;28:1219-1221.
10. Reaven PD, Traustadóttir T, Brennan J, Nader PR: Cardiovascular risk factors associated with insulin resistance in children persist into late adolescence. Diabetes Care 2005;28:148-150.
11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; the Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Engl J Med 2002;346:393-403.
12. The Diabetes Prevention Program: Design and methods for a clinical trial in prevention of type 2 diabetes. Diabetes Care 1999;22:623-634.
13. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A: Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 2003;88:1019-1023.
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-419.
15. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ: Quantitative insulin-sensitivity check index (QUICKI): a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
16. Brandou F, Brun JF, Mercier J: Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab 2005;90:761-767.
17. Lewitt MS, Hall K, Bang P, Brismar K: Altered response of insulin-like growth factor binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metabolism 2005;54:275-280.
18. Suwanichkul A, Allander SV, Morris SL, Powell DR: Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements. J Biol Chem 1994;269:30835-30841.
19. Phillips LS, Pao CI, Villafuerte BC: Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3. Prog Nucleic Acids Res Mol Biol 1998;60:195-265.
20. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM: Portal insulin concentration rather than insulin sensitivity regulate serum sex hormone binding globulin and insulin like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995;80:3227-3232.
21. Levitt Katz LE, Satin-Smith MS, Collett Solberg P, Baker L, Stanley CA, Cohen P: Dual regulation of insulin like growth factor binding protein-1 level by insulin and cortisol during fasting. J Clin Endocrinol Metab 1998;83:4426-4430.
22. Buyalos RP, Pekonen F, Halme JK, Judd HL, Rutanen EM: The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome. Am J Obstet Gynecol 1995;172:932-939.
23. Ibanez L, Potau N, Zampolli M, Rique S, Saenger P, Carrascosa A: Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche. J Clin Endocrinol Metab 1997;82:2283-2288.
24. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, Wilker S, Southern AL, Gambert SR: Insulin like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. J Clin Endocrinol Metab 1996;81:4492-4495.
25. Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N: Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1 and -3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normo-insulinaemic obese children. Clin Endocrinol (Oxf) 1998;48:487-492.
26. Saitoh H, Kamoda T, Nakahara S, Hirano T, Matsui A: Insulin-like growth factor binding protein-1 as a predictor of glucose-stimulated hyperinsulinemia in prepubertal obese children. Eur J Endocrinol 1999;140:231-234.
27. Hwa V, Oh Y, Rosenfeld RG: Insulin like growth factor-binding protein (IGFBP) super family. Endocr Rev 1999;20:761-787.
28. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA, Wilson TA: Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab 1995;80:2282-2288.
29. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
30. Yang Y, Youn JH, Bergman RN: Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol 1987;253:E595-E602.
31. Cutfield WS, Bergman RN, Menon RK, Sperling MA: The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab 1990;70:1644-1650.
32. Sunehag AL, Treuth MS, Toffolo G, Butte NF, Cobelli C, Bier DM, Haymond MW: Glucose production, gluconeogenesis, and insulin sensitivity in children and adolescents: an evaluation of their reproducibility. Pediatr Res 2001;50:115-123.
33. Gower BA, Granger WM, Franklin F, Shewchuk RM, Goran MI: Contribution of insulin secretion and clearance to glucose-induced insulin concentration in African-American and Caucasian children. J Clin Endocrinol Metab 2002;87:2218-2224.
34. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-122.
35. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
36. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS: Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1993;76:44-48.
37. Bao W, Srinivarsan SR, Berenson GS: Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 1996;93:54-59.
38. Bacha F, Saad R, Gunor N, Arslanian SA: Are obesity metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care 2006;29:1599-1604.
39. Barlow SE, Dietz WH: Obesity evaluation and treatment: expert committee recommendations. Pediatrics 1998;102:29-40.
40. American Diabetes Association: Position statement: screening for type 2 diabetes. Diabetes Care 2004;27(Suppl):S11-S14.
41. Porksen N, Nyholm B, Veldhuis JD, Butler PC, Schmitz O: In human at least 75% of insulin secretion arises from punctuated insulin secretory bursts. Am J Physiol 1997;273:E908-E914.
42. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC: Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 2000;85:4491-4499.
43. Stunff CL, Bourgneres P: Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 1994;43:696-702.
44. Martinelli CE Jr, Yateman ME, Cotterill AM, Moreira AC, Camacho-Hubner C: Correlation between cortisol and insulin-like growth factor-binding proteins (IGFBPs) under physiological conditions in children. Clin Endocrinol (Oxf) 1999;50:767-774.